Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05044286 · ClinicalTrials.gov registry record
Longer-Acting PrEP in Transgender and Gender Diverse Texans
A clinical trial, sponsored by University of Texas at Austin.
- Completed
- Registry status
- 565
- Enrollment target
NCT05044286 is a clinical trial that has completed, run by University of Texas at Austin. The registered enrollment target is 565 participants.
The verdict
NCT05044286 has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- 565 participants
- Enrollment target
Study Summary
The long-term goal of this project is to increase uptake and adherence of LA-PrEP in TGD populations in Texas. The central hypothesis is that strategies to increase uptake of LA- PrEP that are patient centered and understand the needs of TGD people will improve uptake and adherence. The objective of this observational study is to investigate barriers, facilitators, and preferences regarding willingness and intention to use LA-PrEP in TGD populations in Texas. Data from this study will support future research on patient centered strategies for uptake and adherence of LA-PrEP in TGD populations.
Interventions
- OTHER no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 565 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05044286
The ClinicalTrials.gov registry entry for NCT05044286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 565 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which no intervention is the first listed.
NCT05044286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05044286 about?
NCT05044286 is a clinical study titled "Longer-Acting PrEP in Transgender and Gender Diverse Texans". The long-term goal of this project is to increase uptake and adherence of LA-PrEP in TGD populations in Texas. The central hypothesis is that strategies to increase uptake of LA- PrEP that are patient centered and understand the needs of TGD people will improve uptake and adherence. The objective of...
What is the current status of trial NCT05044286?
This trial is currently completed. The enrollment target is 565 participants. The study started on 2022-02-01. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT05044286?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT05044286?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.